NM_020806.5:c.800A>G
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_020806.5(GPHN):c.800A>G(p.Asn267Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.007 in 1,608,422 control chromosomes in the GnomAD database, including 59 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_020806.5 missense
Scores
Clinical Significance
Conservation
Publications
- sulfite oxidase deficiency due to molybdenum cofactor deficiency type CInheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, ClinGen
- hereditary hyperekplexiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- complex neurodevelopmental disorderInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00587 AC: 893AN: 152176Hom.: 2 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00653 AC: 1641AN: 251212 AF XY: 0.00664 show subpopulations
GnomAD4 exome AF: 0.00712 AC: 10372AN: 1456128Hom.: 57 Cov.: 28 AF XY: 0.00707 AC XY: 5127AN XY: 724764 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00587 AC: 894AN: 152294Hom.: 2 Cov.: 32 AF XY: 0.00608 AC XY: 453AN XY: 74474 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:3
- -
- -
GPHN: BP4, BS2 -
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A Benign:2
- -
- -
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C;C4551954:Hyperekplexia 1 Benign:1
- -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C Benign:1
- -
GPHN-related disorder Benign:1
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at